Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE)

Jeffrey A Lieberman¹

Affiliations

Affiliation

¹ Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA. jlieberman@columbia.edu

PMID: 17015808
DOI: 10.1001/archpsyc.63.10.1069

Comparative Study

Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE)

Jeffrey A Lieberman. Arch Gen Psychiatry. 2006 Oct.

. 2006 Oct;63(10):1069-72.

doi: 10.1001/archpsyc.63.10.1069.

Author

Jeffrey A Lieberman¹

Affiliation

¹ Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA. jlieberman@columbia.edu

PMID: 17015808
DOI: 10.1001/archpsyc.63.10.1069

No abstract available

PubMed Disclaimer

Comment in

First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
Tandon R, Carpenter WT, Davis JM. Tandon R, et al. Arch Gen Psychiatry. 2007 Aug;64(8):977-8; author reply 979-80. doi: 10.1001/archpsyc.64.8.977. Arch Gen Psychiatry. 2007. PMID: 17679642 No abstract available.
CUtLASS confirms CATIE.
Mintz J, Kopelowicz A. Mintz J, et al. Arch Gen Psychiatry. 2007 Aug;64(8):978; author reply 979-80. doi: 10.1001/archpsyc.64.8.978-a. Arch Gen Psychiatry. 2007. PMID: 17679644 No abstract available.

Comment on

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Lieberman JA, et al. N Engl J Med. 2005 Sep 22;353(12):1209-23. doi: 10.1056/NEJMoa051688. Epub 2005 Sep 19. N Engl J Med. 2005. PMID: 16172203 Clinical Trial.
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Jones PB, et al. Arch Gen Psychiatry. 2006 Oct;63(10):1079-87. doi: 10.1001/archpsyc.63.10.1079. Arch Gen Psychiatry. 2006. PMID: 17015810 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE)

Affiliation

Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE)

Author

Affiliation

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical